HCW Biologics Inc. Reports Results for Quarter Ended June 30, 2026

What Happened

• HCW Biologics Inc. announced its financial results for the quarter ended June 30, 2026 in a press release dated August 14, 2026.
• The company furnished the full text of that press release as Exhibit 99.1 to the Form 8-K and included an interactive XBRL cover page (Exhibit 104).

Key Details

• Filing date: August 14, 2026 (Form 8-K).
• Period covered: quarter ended June 30, 2026.
• Exhibit provided: Press release announcing the results (Exhibit 99.1).
• Interactive XBRL data: Cover Page Interactive Data File embedded (Exhibit 104).

Why It Matters

• This 8-K provides HCW Biologics’ latest quarterly financial results and condition — key information for assessing recent performance, cash position, and near-term outlook.
• Investors should review the furnished press release and the embedded XBRL data for details on revenue, expenses, net income/loss, cash balances, and any management commentary or forward-looking statements that could affect the company’s valuation or trading.